10.51
Cervomed Inc stock is traded at $10.51, with a volume of 83,365.
It is up +2.94% in the last 24 hours and up +4.58% over the past month.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
See More
Previous Close:
$10.21
Open:
$10.26
24h Volume:
83,365
Relative Volume:
0.25
Market Cap:
$97.25M
Revenue:
-
Net Income/Loss:
$-6.42M
P/E Ratio:
-1.8764
EPS:
-5.6013
Net Cash Flow:
$-7.45M
1W Performance:
+9.25%
1M Performance:
+4.58%
6M Performance:
+386.57%
1Y Performance:
-29.13%
Cervomed Inc Stock (CRVO) Company Profile
Name
Cervomed Inc
Sector
Industry
Phone
(617) 744-4400
Address
20 PARK PLAZA, BOSTON
Compare CRVO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CRVO
Cervomed Inc
|
10.51 | 88.85M | 0 | -6.42M | -7.45M | -5.6013 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-13-25 | Upgrade | Chardan Capital Markets | Neutral → Buy |
Dec-17-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
Dec-11-24 | Downgrade | Chardan Capital Markets | Buy → Neutral |
Dec-11-24 | Downgrade | Morgan Stanley | Overweight → Underweight |
Dec-10-24 | Downgrade | D. Boral Capital | Buy → Hold |
Dec-06-24 | Initiated | ROTH MKM | Buy |
Dec-05-24 | Initiated | H.C. Wainwright | Buy |
Sep-18-24 | Initiated | Chardan Capital Markets | Buy |
Jul-26-24 | Initiated | Morgan Stanley | Overweight |
Feb-15-24 | Initiated | Canaccord Genuity | Buy |
Nov-17-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
Mar-21-18 | Initiated | H.C. Wainwright | Buy |
View All
Cervomed Inc Stock (CRVO) Latest News
Will CervoMed Inc. benefit from current market trends2025 Biggest Moves & Long Hold Capital Preservation Tips - 뉴스영
Sector ETF performance correlation with CervoMed Inc.CEO Change & Safe Capital Investment Plans - Newser
Chart based analysis of CervoMed Inc. trendsEarnings Recap Summary & Consistent Return Investment Signals - Newser
CervoMed Inc.’s volatility index tracking explainedPortfolio Value Summary & Long-Term Growth Plans - Newser
What are the risks of holding CervoMed Inc.July 2025 Analyst Calls & Safe Entry Trade Signal Reports - خودرو بانک
Will a bounce in CervoMed Inc. offer an exitTrade Signal Summary & Technical Pattern Alert System - Newser
CervoMed Inc. stock prediction for this weekJuly 2025 Volume & Smart Allocation Stock Reports - Newser
How high can CervoMed Inc. stock goTrade Signal Summary & Free Fast Gain Swing Trade Alerts - Newser
Regression analysis insights on CervoMed Inc. performanceGold Moves & Safe Capital Allocation Plans - Newser
What to expect from CervoMed Inc. in the next 30 days2025 Earnings Impact & Technical Pattern Recognition Alerts - Newser
Is CervoMed Inc. stock bottoming out2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
CervoMed Inc. stock trend forecast2025 Investor Takeaways & Safe Entry Momentum Tips - Newser
Can CervoMed Inc. hit a new high this month2025 Market WrapUp & Daily Price Action Insights - Newser
Measuring CervoMed Inc.’s beta against major indicesJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
Visualizing CervoMed Inc. stock with heatmapsWeekly Trade Summary & AI Optimized Trading Strategy Guides - Newser
How to manage a losing position in CervoMed Inc.Weekly Market Outlook & Weekly High Return Stock Forecasts - Newser
What’s the outlook for CervoMed Inc.’s sector2025 Sector Review & Breakout Confirmation Alerts - خودرو بانک
Can CervoMed Inc. lead its sector in growthMarket Activity Report & Verified Stock Trade Ideas - خودرو بانک
When is the best time to exit CervoMed Inc.2025 Risk Factors & Accurate Intraday Trade Tips - Newser
Will CervoMed Inc. rebound enough to break evenEntry Point & Safe Entry Momentum Tips - Newser
How institutional ownership impacts CervoMed Inc. stockM&A Rumor & Long-Term Safe Investment Ideas - Newser
Smart tools for monitoring CervoMed Inc.’s price actionShare Buyback & Growth Focused Stock Pick Reports - Newser
What indicators show strength in CervoMed Inc.Trade Performance Summary & Weekly Watchlist of Top Performers - Newser
Risk adjusted return profile for CervoMed Inc. analyzed2025 Market WrapUp & Safe Entry Zone Tips - Newser
How does CervoMed Inc. compare to its peersWeekly Profit Summary & Free Community Consensus Stock Picks - خودرو بانک
Using economic indicators to assess CervoMed Inc. potentialJuly 2025 Momentum & Risk Managed Investment Entry Signals - Newser
CervoMed Inc. to Present at Upcoming Investor Conferences in September 2025 - Quiver Quantitative
Is this a good reentry point in CervoMed Inc.Market Performance Report & Stock Portfolio Risk Control - Newser
CervoMed to Participate in Upcoming Investor Conferences - GlobeNewswire
Neurologic Drug Developer CervoMed Announces Dual Healthcare Conference Presentations in September 2025 - Stock Titan
Guidance Update: Can CervoMed Inc. navigate macro headwinds2025 Trading Volume Trends & Expert Approved Momentum Ideas - خودرو بانک
Why CervoMed Inc. is moving todayQuarterly Risk Review & Low Volatility Stock Recommendations - Newser
Is CervoMed Inc. stock a good pick for beginnersJuly 2025 Fed Impact & Weekly High Conviction Trade Ideas - خودرو بانک
Earnings visualization tools for CervoMed Inc.Market Trend Review & Advanced Swing Trade Entry Alerts - Newser
Is CervoMed Inc. showing signs of accumulationMarket Trend Review & Growth Focused Stock Reports - Newser
EPS Watch: Will CervoMed Inc. benefit from government policyJuly 2025 Movers & Weekly Momentum Stock Picks - خودرو بانک
CervoMed's 15min chart shows KDJ Death Cross, bearish Marubozu formation detected. - AInvest
MACD Signals Flash Warning for CervoMed Inc. Stock getLinesFromResByArray error: size == 0 - thegnnews.com
Cervomed Inc Stock (CRVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):